"A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding (Q44226728)

1 December 2017

"A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding (English)

1 reference

1 December 2017

1 reference

1 reference

Christophe Bureau

1

1 reference

1 December 2017

Jean-Marie Péron

2

1 reference

1 December 2017

Laurent Alric

3

1 reference

1 December 2017

Joséphine Morales

4

1 reference

1 December 2017

Jérôme Sanchez

5

1 reference

1 December 2017

Karl Barange

6

1 reference

1 December 2017

Jean-Louis Payen

7

1 reference

1 December 2017

Jean-Pierre Vinel

8

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

1 December 2017

1 reference

1 December 2017

36

1 reference

1 December 2017

1361-1366

1 reference

1 December 2017

6

1 reference

Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.

1 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Portal hypertension and variceal bleeding: an AASLD single topic symposium

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Hemodynamic evaluation of molsidomine: a vasodilator with antianginal properties in patients with alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Failure of haemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranolol

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Clinical vs haemodynamic response to drugs in portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Short-term effects of propranolol on portal venous pressure

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Correlation of duplex sonography findings and portal pressure in 375 patients with portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360611

7 January 2021

Identifiers

DOI

10.1002/HEP.1840360611

1 reference

1 December 2017

1 reference